[ASTRO] YoY Cumulative Quarter Result on 31-Oct-2017 [#3]

Stock
[ASTRO] ASTRO MALAYSIA HOLDINGS BERHAD
Announcement Date
06-Dec-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jan-2018
Quarter
31-Oct-2017 [#3]
Profit Trend
QoQ- 33.17%
YoY- 23.03%
Quarter Report
Latest QR
Upcoming QR
ASTRO's Result
ASTRO's Financial Summary
View:
Show?
Cumulative Result
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
Revenue 3,250,946 3,686,159 4,111,247 4,142,500 4,215,159 4,073,565 3,883,214 -2.91%
PBT 491,148 666,774 479,789 814,712 657,735 551,184 519,065 -0.91%
Tax -114,838 -159,899 -137,606 -231,271 -183,693 -146,035 -143,089 -3.59%
NP 376,310 506,875 342,183 583,441 474,042 405,149 375,976 0.01%
-
NP to SH 372,021 516,379 344,523 588,849 478,606 411,551 379,400 -0.32%
-
Tax Rate 23.38% 23.98% 28.68% 28.39% 27.93% 26.49% 27.57% -
Total Cost 2,874,636 3,179,284 3,769,064 3,559,059 3,741,117 3,668,416 3,507,238 -3.25%
-
Net Worth 1,003,271 831,680 614,718 664,287 591,617 662,852 612,237 8.57%
Dividend
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
Div 208,580 312,858 391,042 468,909 468,711 429,240 350,815 -8.29%
Div Payout % 56.07% 60.59% 113.50% 79.63% 97.93% 104.30% 92.47% -
Equity
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
Net Worth 1,003,271 831,680 614,718 664,287 591,617 662,852 612,237 8.57%
NOSH 5,214,506 5,214,506 5,214,314 5,213,883 5,207,900 5,202,920 5,197,260 0.05%
Ratio Analysis
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
NP Margin 11.58% 13.75% 8.32% 14.08% 11.25% 9.95% 9.68% -
ROE 37.08% 62.09% 56.05% 88.64% 80.90% 62.09% 61.97% -
Per Share
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
RPS 62.34 70.69 78.85 79.51 80.94 78.29 74.72 -2.97%
EPS 7.13 9.90 6.61 11.30 9.19 7.91 7.30 -0.39%
DPS 4.00 6.00 7.50 9.00 9.00 8.25 6.75 -8.34%
NAPS 0.1924 0.1595 0.1179 0.1275 0.1136 0.1274 0.1178 8.51%
Adjusted Per Share Value based on latest NOSH - 5,213,883
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
RPS 62.29 70.63 78.77 79.37 80.77 78.05 74.41 -2.91%
EPS 7.13 9.89 6.60 11.28 9.17 7.89 7.27 -0.32%
DPS 4.00 5.99 7.49 8.98 8.98 8.22 6.72 -8.27%
NAPS 0.1922 0.1594 0.1178 0.1273 0.1134 0.127 0.1173 8.57%
Price Multiplier on Financial Quarter End Date
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
Date 30/10/20 31/10/19 31/10/18 31/10/17 31/10/16 30/10/15 31/10/14 -
Price 0.73 1.35 1.35 2.81 2.85 2.86 3.30 -
P/RPS 1.17 1.91 1.71 3.53 3.52 3.65 4.42 -19.85%
P/EPS 10.23 13.63 20.43 24.86 31.01 36.16 45.21 -21.92%
EY 9.77 7.34 4.89 4.02 3.22 2.77 2.21 28.08%
DY 5.48 4.44 5.56 3.20 3.16 2.88 2.05 17.78%
P/NAPS 3.79 8.46 11.45 22.04 25.09 22.45 28.01 -28.32%
Price Multiplier on Announcement Date
31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 31/10/15 31/10/14 CAGR
Date 03/12/20 04/12/19 05/12/18 06/12/17 07/12/16 08/12/15 11/12/14 -
Price 0.88 1.36 1.29 2.80 2.65 2.86 3.33 -
P/RPS 1.41 1.92 1.64 3.52 3.27 3.65 4.46 -17.44%
P/EPS 12.33 13.73 19.52 24.77 28.84 36.16 45.62 -19.57%
EY 8.11 7.28 5.12 4.04 3.47 2.77 2.19 24.35%
DY 4.55 4.41 5.81 3.21 3.40 2.88 2.03 14.38%
P/NAPS 4.57 8.53 10.94 21.96 23.33 22.45 28.27 -26.17%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment